Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consider and approve Pursuant to Regulation ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Biogen Pharmachem Industries has informed BSE that its Board of Directors will meet on Wednesday, 5th August 2026. The key agenda item is to approve and take on record the unaudited financial results for the first quarter ended 30th June 2026. The notice also includes a standard 'any other matter with the permission of the board' clause. This is a routine regulatory filing under SEBI LODR Regulation 29, signed by Director Kelash Bunkar, and precedes the company's quarterly results announcement.
This is a standard advance intimation of an upcoming board meeting and does not itself contain any financial data or material decisions. Shareholders should watch for the actual Q1 results, expected to be announced on or shortly after 5th August 2026, for insights into the company's quarterly performance.